Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.3.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.2.3.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.205EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.205ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.205ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.205EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.205EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.205ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.205ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.110EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.110EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.110ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.110ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.110EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.110EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.110ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.110ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.434EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.434EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.434ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.434ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.434EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.434EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.434ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.434ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.4.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.4.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.181EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.181EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.181ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.181ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.181EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.181EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.181ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.181ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used